Rossari Biotech (ROSSARI)
STALWARTFairStock Score: 33/100 — RISKY
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹511.45 |
| Market Cap | ₹2,748.4 Cr |
| P/E Ratio | 19.96 |
| ROCE | 15.8% |
| ROE | 11.91% |
| Dividend Yield | 0.1% |
| Profit Growth | 3.38% |
| Debt/Equity | 0.28 |
| Sales Growth | 13.45% |
| Promoter Holding | 68.16% |
| 52-Week Range | ₹375 — ₹766 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹183.75 |
Rossari Biotech trades with a P/E ratio of 19.96, ROCE of 15.8%, ROE of 11.91%, profit growth of 3.38%, debt-to-equity of 0.28. The FairStock Score of 33/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer